Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2019 for Harvard Apparatus Regenerative Technology, Inc., €46k.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
-23.7%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -39.9%Entry US$35,831.25 · Close at T+365 US$21,528.00
- -68.9%Entry US$93,249.00 · Close at T+365 US$28,986.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey E. Young: trading record in brief
Jeffrey E. Young is a declared insider at 4 companies; the most frequent names are Critical Therapeutics Inc, Juniper Pharmaceuticals Inc and Tempest Therapeutics, Inc. The record holds 14 filings, for trades running from 27 December 2006 to 30 September 2019.
Every open-market trade on record is a purchase: 2 purchases worth €41k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 10 share grants.
The record was last updated on 2 October 2019 with a share grant (€46k) in Harvard Apparatus Regenerative Technology, Inc. The most recent open-market purchase was published on 7 October 2015, 4,034 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey E. Young
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
25,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001144204-19-046964:0
30,413 shares@ US$11.5096.3% of flowCommon StockSEC:0001209191-18-046773:0
18,400 shares0Common StockSEC:0001209191-18-009524:0
5,000 shares0Common StockSEC:0001209191-18-009018:0
1,737 shares@ US$8.403.7% of flowCommon StockSEC:0001209191-18-009018:1
50,000 shares0Common StockSEC:0001179110-15-015929:0
3,450 shares@ US$10.70Common StockSEC:0001179110-15-013904:0
Canonical exit: 3 Jan 2016 (T+90)
300 shares@ US$29.93Common StockSEC:0001179110-15-006173:0
Canonical exit: 7 Jul 2015 (T+90)
220 shares@ US$3.50Common StockSEC:0001209191-08-060794:0
4,270 shares@ US$1.28Common StockSEC:0001209191-07-072118:0
25,000 shares0Common StockSEC:0001209191-07-062349:0
3,039 shares@ US$1.59Common StockSEC:0001209191-07-034735:0
26,700 shares@ US$26.70Common StockSEC:0001209191-06-067306:0
13 of 13 declarations
